| Established | January 2014 |
|---|---|
| Focus | Medical research |
| Chair | Dr Robert Edgar |
| CEO and Director | Professor Elizabeth Hartland |
| Faculty | Monash University |
| Staff | 450 (in 2016) |
| Formerly called | |
| Address | 27-31 Wright St, Clayton VIC Australia |
| Location | , , Australia |
| Website | hudson |
Hudson Institute of Medical Research is a leading Australian medical research institute recognised internationally for discovery science and translational research.
It is an independent, not-for-profit medical research institute, based in the Melbourne suburb of Clayton in Victoria hosting approximately 450 researchers, postgraduate students and support staff. Hudson Institute strives to improve human health through groundbreaking, collaborative, medical research discoveries and the translation of these to real world impact. Its scientists research five areas of medical need: Inflammation, Reproductive Health and Pregnancy, Infant and Child Health, Cancer, and Hormones and Health. [1]
The current director and CEO is distinguished researcher and international authority on microbiology and immunology, Professor Elizabeth Hartland. [2]
The institute is partnered with Monash University and Monash Health, and is co-located with both organisations at the Monash Health Translation Precinct in Clayton. [3]
The Institute's purpose is stated as ‘unravelling the mysteries of nature to cure disease’. [4]
Hudson Institute of Medical Research is organised into five specialist research centres :
Within these centres, 45 research groups undertake basic, translational and clinical research into a range of diseases.
Hudson Institute of Medical Research was formed in January 2014 through a merger of the Monash Institute of Medical Research and Prince Henry's Institute of Medical Research. [1]
Hudson Institute of Medical Research was named in honour of the late Professor Bryan Hudson, the founding Professor of Medicine at Monash University and first director of the Prince Henry's Hospital Medical Research Centre, which later became Prince Henry's Institute of Medical Research. [13]
Professor Hudson was one of Australia's leading endocrinologists, and a renowned physician-scientist responsible for early work on the male reproductive hormone, Inhibin. [14]
The Institute has a large student population, predominantly enrolled through Monash University, and hosts more than 170 postgraduate (Honours, Masters, BmedSci, and PhD) students each year. [15]
A new federally-funded $87.5 million Monash Health Translation Precinct Translational Research Facility (TRF) was officially opened by then Australian Health Minister Sussan Ley MP in March 2016. [16]
The facility contains research laboratory space, a platform technologies floor and a dedicated clinical trials centre, with eight beds and 21 chairs for the purpose of translating research into patient treatments. [16]
The Institute's scientists and students have access to the MHTP Technology Platforms, which contain the following capabilities: [17]
WEHI, previously known as the Walter and Eliza Hall Institute of Medical Research, and as the Walter and Eliza Hall Institute, is Australia's oldest medical research institute. Sir Frank Macfarlane Burnet, who won the Nobel Prize in 1960 for his work in immunology, was director from 1944 to 1965. Burnet developed the ideas of clonal selection and acquired immune tolerance. Later, Professor Donald Metcalf discovered and characterised colony-stimulating factors. As of 2015, the institute hosted more than 750 researchers who work to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C.
UC San Diego Health is the academic health system of the University of California, San Diego in San Diego, California. It is the only academic health system serving San Diego and has one of only two adult Level I trauma centers in the region. In operation since 1966, it comprises the UC San Diego Medical Center in Hillcrest as well as the; Jacobs Medical Center; Moores Cancer Center; Shiley Eye Institute; Sulpizio Cardiovascular Center, and Koman Family Outpatient Pavilion, all in La Jolla. It also includes several outpatient sites located throughout San Diego County. The health system works closely with the university's School of Medicine and Skaggs School of Pharmacy to provide training to medical and pharmacy students and advanced clinical care to patients.
The Peter MacCallum Cancer Centre, also known as the Peter MacCallum Cancer Institute and commonly abbreviated as Peter Mac, is an Australian oncology research institute, cancer treatment and professional oncologist training centre located in Melbourne, Victoria. The centre is named in honour of Sir Peter MacCallum. Since June 2016, the centre has been located within the Victorian Comprehensive Cancer Centre (VCCC) in Parkville.
The QIMR Berghofer Medical Research Institute is an Australian medical research institute located in Herston, Brisbane, in the state of Queensland. QIMR was established in 1945 by the Government of Queensland through the enactment of the Queensland Institute of Medical Research Act 1945 (Qld). Previously known as the Queensland Institute of Medical Research (QIMR), the original purpose of the institute was to further the study of tropical diseases in North Queensland. The current director is Professor Fabienne Mackay. The institute is a registered charity. In 2021, the institute was named as one of the Queensland Greats by the Queensland Government.
The Institute of Health and Biomedical Innovation (IHBI) was an Australian collaborative medical research institute established in 2000 and based at the Queensland University of Technology (QUT) in Brisbane, Queensland. While the bulk of the institute was located at a purpose built facility on the Kelvin Grove campus of QUT, a number of projects were conducted at sites across the two main QUT campuses and at multi-partner research institutes adjoining major hospitals. Research was also conducted at IHBI's Medical Engineering Research Facility (MERF), in the grounds of the Prince Charles Hospital.
The John Curtin School of Medical Research (JCSMR) is an Australian multidisciplinary translational medical research institute and postgraduate education centre that forms part of the Australian National University (ANU) in Canberra. The school was founded in 1948 as a result of the vision of Nobel Laureate Sir Howard Florey and was named in honour of Australia's World War II Prime Minister John Curtin, who had died in office a few years earlier.
The Burnet Institute is an Australian medical institute that combines medical research in the laboratory and the field, with public health action to address major health issues affecting disadvantaged communities in Australia, and internationally.
Sanford Burnham Prebys is a 501(c)(3) non-profit medical research institute focusing on basic and translational research, with major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute also specializes in stem cell research and drug discovery technologies.
The Monash University Faculty of Medicine, Nursing and Health Sciences is an Australian health care provider. It comprises 10 schools, teaching and clinical centers and research institutes. The faculty offers undergraduate, postgraduate and professional education programs in medicine, nursing and allied health, and is a member of the M8 Alliance of Academic Health Centers, Universities and National Academies.
The Australian Regenerative Medicine Institute (ARMI) is an Australian medical research institute. Opened in April 2009, the institute is based at the Clayton campus of Monash University, in the Monash Science Technology Research and Innovation Precinct.
Translational research is research aimed at translating (converting) results in basic research into results that directly benefit humans. The term is used in science and technology, especially in biology and medical science. As such, translational research forms a subset of applied research.
The Monash Institute of Medical Research (MIMR), was an Australian medical research institute located in the Melbourne suburb of Clayton, Victoria, consisting of 400 scientists and students belonging to the Faculty of Medicine, Nursing and Health Sciences at Monash University. In January 2014 the Institute merged with Prince Henry's Institute of Medical Research and has since been renamed the Hudson Institute of Medical Research.
Douglas "Doug" James Hilton is an Australian molecular biologist. He is the Director of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia and Head of the Department of Medical Biology at the University of Melbourne. His research has focused on cytokines, signal transduction pathways and the regulation of blood cell formation (hematopoiesis). Since 2014, Hilton has been the President of the Association of the Australian Medical Research Institutes (AAMRI).
The Translational Research Institute (TRI) is Australia's first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.
Health Translation Queensland is the first Advanced Health Research Translation Centre in Queensland, Australia. The organisation’s purpose is to strengthen the linkages between healthcare, research and education in order to deliver better health outcomes for the community. By encouraging and supporting collaboration, BDHP assists the translation and integration of cutting-edge research and innovation into healthcare delivery.
Bryan Raymond George Williams Hon. FRSNZ, FAA is a molecular biologist from New Zealand, with expertise in innate immunity and cancer biology. He is emeritus director and distinguished scientist at the Hudson Institute of Medical Research in Melbourne, Australia, and professor in the Department of Molecular and Translational Science at Monash University.
Lois Adrienne Salamonsen is an expert in uterine and endometrium biology. Her research focuses on the mechanisms underlying endometrial remodelling. She is a Fellow of the Australian Academy of Science.
Richard Ferrero is a microbiologist. He is a senior research fellow of the National Health and Medical Research Council (NHMRC). In the Centre for Innate Immunity and Infectious Diseases at the Hudson Institute, he also holds the position of senior scientist and head of the Gastrointestinal Infection and Inflammation Research Group.
Tania Sorrell is an Australian infectious disease physician who is a Professor and Director of the Marie Bashir Institute for Infectious Diseases and Biosecurity at the University of Sydney. She serves as Chair of the National Health and Medical Research Council Research Translation Faculty Steering Group on New and Emerging Health Threats. She is interested in the diagnosis, prevention and treatment of infectious diseases.
Fabienne Mackay is a French Australian research immunologist and institutional leader within the Australian medical research, education and innovation sectors. She is the Director and CEO of the QIMR Berghofer Medical Research Institute since 2020, after being the inaugural Head of the School of Biomedical Sciences at the University of Melbourne during the preceding five years. She is also an Honorary Professor at the Faculties of Medicine of the University of Queensland and the University of Melbourne. Her work has attracted public attention for its contribution to the pathophysiological understanding and treatment of lupus and other autoimmune diseases. Mackay has been notably awarded, achieving international reputation for her widely cited research describing B-cell activating factor (BAFF) and other cytokines of the TNF receptor superfamily, and their roles in B cell physiology, autoimmunity and cancer. She is an elected Fellow of the Australian Academy of Health and Medical Sciences.
